Ampa builds scalable brain stimulation technology to eradicate despair.
Around the world, millions are living with mental health challenges that don’t respond to conventional treatments. The impact on individuals, families, and communities is profound. Ampa translates cutting-edge neuroscience into practical tools that help people restore balance, resilience, and mental well-being.
Our mission is to help one billion people reach remission from mental and neurological disorders.
We are here for people struggling with mental health disorders. Every decision— what we build, how we work, who we hire— is grounded in what’s right for patients. Healing a billion people is our north star, which is why we prioritize access, effectiveness, and affordability.
We are here to help a billion people get to remission. It is a wildly audacious goal, and yet we nonetheless have faith that it is achievable in our lifetimes. Through vision, purpose, and dedication, we at Ampa will stop at nothing to to fulfill the mission before us.
At Ampa, excellence is not a finish line; it is how we show up every day, in every moment. We hold ourselves to uncompromising standards— driven by what's at stake: real human lives. The pressure of building incredible products is the crucible that forges us into better versions of ourselves. Great people make great products, and great products make great people— the cycle strengthens us.
We don’t just see patients, clients, investors, vendors, or employees— we see community. Ampa brings together everyone in the service of our shared mission. We support one another through the hard work. We can face any challenge, if we face it together.
At Ampa, we share a common vision: to make this powerful treatment accessible to every person who needs it. To bring that vision to life, we’ve built a team of talented, dedicated individuals who are passionate about mental health and committed to advancing care. Our advisors include some of the world’s leading experts in TMS research, engineering, and clinical practice.
With medications, the cost of delivery and development go up every year. But TMS is a technology, not a molecule. Like computers, batteries, and other advanced technologies, its capabilities grow while costs steadily decline.
Don is a neuroscientist and entrepreneur with extensive experience in product, neurotechnology, and evangelism. At Ampa, Don is committed to using developments in neuroscience and AI to create breakthroughs in mental health and brain function. His research has been featured on ABC, ESPN, TIME magazine, and The Economist. Over a million people have viewed his TEDx talk “neurohacking: rewiring your brain.” He has been an opinion leader for a range of news outlets including The Wall Street Journal and The Economist. Don completed dual degrees from Stanford—a B.S. in Physics and a B.A. in Economics—and a Ph.D. in Neuroscience from UCLA.
Outside of Ampa, Dr. Jonathan Downar is an Adjunct Professor in the Department of Psychiatry and Institute of Medical Science at the University of Toronto. Over the last quarter-century, he has published over 180 peer-reviewed articles on brain imaging and on TMS, in journals including Lancet, Nature Medicine, Nature Neuroscience, JAMA Psychiatry, and the American Journal of Psychiatry. He is the senior author of the landmark THREE-D study, demonstrating that TMS treatments could be reduced from 38 min sessions to 3 minute sessions with no loss of efficacy. Dr. Downar’s work focuses on translating neuroscience breakthroughs into practical treatment tools that can help people around the world recover from mental health disorders.
© 2025 Ampa Inc. All rights reserved.
